BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gilbert RM, Standaert DG. Bridging the Gaps: More Inclusive Research Needed to Fully Understand Parkinson's Disease. Mov Disord 2020;35:231-4. [DOI: 10.1002/mds.27906] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators. Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials 2022;23:855. [PMID: 36203214 DOI: 10.1186/s13063-022-06703-0] [Reference Citation Analysis]
2 McKee KE, Gilbert RM, Spigle WA, Tilley BC, Corcos DM. Inclusion of Non-English-Speaking Participants in Studies of Parkinson's Disease: A Call to Action. Mov Disord 2022. [PMID: 35929651 DOI: 10.1002/mds.29179] [Reference Citation Analysis]
3 Magalhães P, Lashuel HA. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies. NPJ Parkinsons Dis 2022;8:93. [PMID: 35869066 DOI: 10.1038/s41531-022-00357-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Subramanian I, Mathur S, Oosterbaan A, Flanagan R, Keener AM, Moro E. Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies. Movement Disorders. [DOI: 10.1002/mds.28921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Naha A, Banerjee S, Debroy R, Basu S, Ashok G, Priyamvada P, Kumar H, Preethi A, Singh H, Anbarasu A, Ramaiah S. Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease. Computational and Structural Biotechnology Journal 2022;20:4271-87. [DOI: 10.1016/j.csbj.2022.08.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mok KY; East Asian Parkinson Disease Genomics Consortium. The East Asian Parkinson Disease Genomics Consortium. Lancet Neurol 2021;20:982. [PMID: 34800411 DOI: 10.1016/S1474-4422(21)00373-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rouan J, Velazquez G, Freischlag J, Kibbe MR. Publication bias is the consequence of a lack of diversity, equity, and inclusion. J Vasc Surg 2021;74:111S-7S. [PMID: 34303450 DOI: 10.1016/j.jvs.2021.03.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, Riley L, Tanner CM; Fox Insight Study. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience. J Parkinsons Dis 2020;10:665-75. [PMID: 32250321 DOI: 10.3233/JPD-191901] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
9 Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K, Kopil C, Tanner CM, Marrason C; behalf of the Fox Insight Study. Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. J Parkinsons Dis 2020;10:677-91. [PMID: 31958097 DOI: 10.3233/JPD-191808] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
10 Xie T, Liao C, Lee D, Yu H, Padmanaban M, Kang W, Johnson J, Alshaikh J, Yuen C, Burns M, Chiu BC. Disparities in diagnosis, treatment and survival between Black and White Parkinson patients. Parkinsonism Relat Disord 2021;87:7-12. [PMID: 33905958 DOI: 10.1016/j.parkreldis.2021.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ojukwu DI, Andruska KM, Halpern CH. Lessons From George Floyd: Racial Inequalities in the Treatment of Parkinson's Disease. Mov Disord 2021;36:599-603. [PMID: 33200830 DOI: 10.1002/mds.28388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vaswani PA, Tropea TF, Dahodwala N. Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention. Neurotherapeutics 2020;17:1724-35. [PMID: 33150545 DOI: 10.1007/s13311-020-00960-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Di Luca DG, Sambursky JA, Margolesky J, Cordeiro JG, Diaz A, Shpiner DS, Moore HP, Singer C, Luca C. Minority Enrollment in Parkinson's Disease Clinical Trials: Meta-Analysis and Systematic Review of Studies Evaluating Treatment of Neuropsychiatric Symptoms. J Parkinsons Dis 2020;10:1709-16. [PMID: 32894250 DOI: 10.3233/JPD-202045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Di Luca DG, Feldman M, Jimsheleishvili S, Margolesky J, Cordeiro JG, Diaz A, Shpiner DS, Moore HP, Singer C, Li H, Luca C. Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord 2020;77:13-7. [PMID: 32575002 DOI: 10.1016/j.parkreldis.2020.06.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]